| Bel Air Family Care Llc | |
|
2014 S Tollgate Rd Ste 211-212 Bel Air MD 21015-5903 | |
| (410) 670-9200 | |
| (410) 670-9201 |
| Full Name | Bel Air Family Care Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 2014 S Tollgate Rd Ste 211-212, Bel Air, Maryland |
| Authorized Official Name and Position | Yuvraj Kamboj (AUTHORIZED OFFICIAL) |
| Authorized Official Contact | 4106709200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bel Air Family Care Llc 918 Sidehill Dr Bel Air MD 21015-6364 Ph: (410) 670-9200 | Bel Air Family Care Llc 2014 S Tollgate Rd Ste 211-212 Bel Air MD 21015-5903 Ph: (410) 670-9200 |
| NPI Number | 1063923886 |
|---|---|
| Provider Enumeration Date | 10/19/2017 |
| Last Update Date | 01/19/2018 |
| Medicare PECOS PAC ID | 3779843339 |
|---|---|
| Medicare Enrollment ID | O20180131000670 |
News Archive
Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.
The Guyanese Ministry of Health on Tuesday announced it will provide $450,000 to 16 nongovernmental organizations to conduct HIV/AIDS programs nationwide, the Stabroek News reports.
Research released today reveals new mechanisms and areas of the brain associated with anxiety and depression, presenting possible targets to understand and treat these debilitating mental illnesses.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063923886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Maryland) | Primary |
| Provider Name | Yuvraj Kamboj |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528237930 PECOS PAC ID: 4284821687 Enrollment ID: I20120629000394 |
News Archive
Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.
The Guyanese Ministry of Health on Tuesday announced it will provide $450,000 to 16 nongovernmental organizations to conduct HIV/AIDS programs nationwide, the Stabroek News reports.
Research released today reveals new mechanisms and areas of the brain associated with anxiety and depression, presenting possible targets to understand and treat these debilitating mental illnesses.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 9 days ago
News Archive
Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.
The Guyanese Ministry of Health on Tuesday announced it will provide $450,000 to 16 nongovernmental organizations to conduct HIV/AIDS programs nationwide, the Stabroek News reports.
Research released today reveals new mechanisms and areas of the brain associated with anxiety and depression, presenting possible targets to understand and treat these debilitating mental illnesses.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
› Verified 9 days ago
Plumtree Family Health Center, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 104 Plumtree Rd Ste 102, Bel Air, MD 21015 Phone: 410-569-4224 Fax: 410-569-4368 | |
Upper Chesapeake Primary Care,llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 520 Upper Chesapeake Dr Ste 308, Bel Air, MD 21014 Phone: 443-643-4800 | |
Harford Primary Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 W Ring Factory Rd, Bel Air, MD 21014 Phone: 410-220-6944 | |
Harford Primary Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1909 Emmorton Rd, Bel Air, MD 21015 Phone: 410-803-1400 | |
Favor Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4b North Ave Ste 302, Bel Air, MD 21014 Phone: 410-403-3299 Fax: 410-862-4350 | |
Upper Chesapeake Radiation Oncology, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 510 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-3500 |